Bitter gourd (Momordica charantia) possess developmental toxicity as revealed by screening the seeds and fruit extracts in zebrafish embryos
Abstract Background Bitter gourd (Momordica charantia) has attracted the focus of researchers owing to its excellent anti-diabetic action. The beneficial effect of Momordica charantia on heart has been reported by in vitro and in vivo studies. However the developmental toxicity or potential risk of...
Saved in:
Main Authors: | Muhammad Farooq Khan (Author), Nael Abutaha (Author), Fahd A. Nasr (Author), Ali S. Alqahtani (Author), Omar M. Noman (Author), Mohammad A. M. Wadaan (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2019-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
BG-4 from Bitter Gourd (<i>Momordica charantia</i>) Differentially Affects Inflammation In Vitro and In Vivo
by: Andrea Nieto-Veloza, et al.
Published: (2019) -
Co-electrospun nanofibrous mats loaded with bitter gourd (Momordica charantia) extract as the wound dressing materials: in vitro and in vivo study
by: Mohammad Saeid Salami, et al.
Published: (2021) -
Evaluation of phytochemical and pharmacological properties of seeds of Momordica charantia
by: Sumyya Zahan, et al.
Published: (2020) -
In silico study of the active compounds in bitter melon (Momordica charantia L) as antidiabetic medication
by: Ruswanto Ruswanto, et al.
Published: (2018) -
<it>Momordica charantia </it>(bitter melon) inhibits primary human adipocyte differentiation by modulating adipogenic genes
by: Nerurkar Vivek R, et al.
Published: (2010)